nancy lin, md, explores the role of cdk4/6 inhibitors in metastatic breast cancer management
Published 4 years ago • 37 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
2:27
nancy lin, md, on breast cancer treatment | dana-farber cancer institute
-
2:31
cdk4/6 inhibitors: a hot topic in breast cancer treatment
-
14:18
a new treatment for breast cancer patients with brain metastases: an interview with dr. nancy lin
-
8:09
what is metastatic breast cancer? | dana-farber cancer institute
-
8:21
cancer metastasis in the bones - all symptoms
-
8:19
lymph nodes and breast cancer
-
14:22
she lives with metastatic cancer
-
1:19
dr. lin on the treatment landscape in her2 metastatic breast cancer
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
3:45
new treatments for metastatic breast cancer
-
2:48
kevin kalinsky, md, summarizes recent clinical data regarding the role of cdk 4/6 inhibitors
-
2:43
what is metastatic breast cancer?
-
1:56
how clinicals trial differ from standard care in metastatic breast cancer treatment
-
2:43
what is metastatic breast cancer?
-
23:00
what's new in metastatic breast cancer research | dana-farber cancer institute
-
2:43
the embrace metastatic breast cancer program | dana-farber cancer institute
-
2:26
cdk inhibitors in metastatic hormone-driven breast cancer
-
5:00
understanding breast cancer
-
15:14
metastatic breast cancer -- an introduction
-
2:42
metastatic breast cancer: treatment and beyond
-
3:54
in depth with dr. nancy demore